| abstract |
isolated cell, isolated cell population, permanent or decellularized degradable matrix or synthetic structure, and method for treating an individual. new angiogenic cells from amnion related to adherent cells derived from amnion are provided herein, and populations of such cells and compositions comprising them. methods for obtaining such cells and methods of using the cells in treating individuals are further provided herein. |